Literature DB >> 8540708

Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy.

R Stahlmann1, C Förster, M Shakibaei, J Vormann, T Günther, H J Merker.   

Abstract

Quinolones accumulate in cartilage, and because they form chelate complexes with divalent cations, they possess the potential to induce a deficiency of functionally available magnesium. To test the hypothesis that quinolone-induced arthropathy is caused (or aggravated) by magnesium deficiency in cartilage, we induced magnesium deficiency by feeding juvenile rats a magnesium-deficient diet for 9 days and treated the rats with single oral doses of ofloxacin (0, 100, 300, 600, or 1,200 mg/kg of body weight) during this period. Additional groups of juvenile rats on a normal diet were treated with ofloxacin correspondingly. Typical cartilage lesions (e.g., swollen matrix, cleft formation) were found in knee joints of all magnesium-deficient rats, including those without ofloxacin treatment. Lesions in these groups were not distinguishable from lesions induced by a single dose of 600 mg of ofloxacin per kg of body weight or higher in rats on a normal diet. Ofloxacin levels in plasma after 600 mg/kg of body weight were approximately 10-fold higher than those in humans during therapy with this quinolone. Lesions in rats treated with ofloxacin plus magnesium deficiency were more pronounced than those in rats with normal magnesium concentrations. After intake of a magnesium-deficient diet for 9 days, the magnesium concentration in serum (mean +/- standard deviation) was 0.18 +/- 0.05 mmol/liter (control on normal diet, 0.82 +/- 0.10 mmol/liter). Magnesium concentrations in bone (femur) and cartilage (processus xiphoideus) samples were 64.7 +/- 10.5 and 14.3 +/- 3.9 mmol/kg of dry weight, respectively, which corresponded to approximately 50% of the concentrations measured in controls on a normal diet. It was concluded that quinolone-induced arthropathy is probably caused by a deficit of available magnesium in joint cartilage due to the formation of quinolone-magnesium chelate complexes. If juvenile patients must be treated with quinolones for serious infections, it seems prudent to ensure that these patients do not have a disturbed magnesium balance.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8540708      PMCID: PMC162873          DOI: 10.1128/AAC.39.9.2013

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  25 in total

Review 1.  Role of the new quinolones in pediatric practice.

Authors:  U B Schaad
Journal:  Pediatr Infect Dis J       Date:  1992-12       Impact factor: 2.129

Review 2.  Lack of quinolone-induced arthropathy in children.

Authors:  U B Schaad; J Wedgwood
Journal:  J Antimicrob Chemother       Date:  1992-10       Impact factor: 5.790

3.  A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.

Authors:  X Chevalier; E Albengres; M C Voisin; J P Tillement; B Larget-Piet
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

4.  Quinolone binding to DNA is mediated by magnesium ions.

Authors:  G Palù; S Valisena; G Ciarrocchi; B Gatto; M Palumbo
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

5.  Morphologic and biochemical changes in articular cartilages of immature beagle dogs dosed with difloxacin.

Authors:  J E Burkhardt; M A Hill; W W Carlton
Journal:  Toxicol Pathol       Date:  1992       Impact factor: 1.902

6.  Arthropathy secondary to ciprofloxacin in an adult cystic fibrosis patient.

Authors:  W M Samuelson; R A Pleasants; M S Whitaker
Journal:  Ann Pharmacother       Date:  1993-03       Impact factor: 3.154

7.  Integrin-mediated attachment of articular chondrocytes to extracellular matrix proteins.

Authors:  R F Loeser
Journal:  Arthritis Rheum       Date:  1993-08

8.  Beta 1 integrins mediate chondrocyte interaction with type I collagen, type II collagen, and fibronectin.

Authors:  M Enomoto; P S Leboy; A S Menko; D Boettiger
Journal:  Exp Cell Res       Date:  1993-04       Impact factor: 3.905

9.  Effects of difloxacin on the metabolism of glycosaminoglycans and collagen in organ cultures of articular cartilage.

Authors:  J E Burkhardt; M A Hill; C H Lamar; G N Smith; W W Carlton
Journal:  Fundam Appl Toxicol       Date:  1993-02

Review 10.  Quinolone arthropathy--acute toxicity to immature articular cartilage.

Authors:  A W Gough; O B Kasali; R E Sigler; V Baragi
Journal:  Toxicol Pathol       Date:  1992       Impact factor: 1.902

View more
  18 in total

1.  Serum concentrations and pharmacokinetics of enrofloxacin after intravenous and intragastric administration to mares.

Authors:  G R Haines; M P Brown; R R Gronwall; K A Merritt
Journal:  Can J Vet Res       Date:  2000-07       Impact factor: 1.310

2.  Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet.

Authors:  M Shakibaei; K Pfister; R Schwabe; J Vormann; R Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 4.  Joint disorders in cystic fibrosis.

Authors:  M A Turner; E Baildam; L Patel; T J David
Journal:  J R Soc Med       Date:  1997       Impact factor: 5.344

5.  Diminished ciprofloxacin-induced chondrotoxicity by supplementation with magnesium and vitamin E in immature rats.

Authors:  Kerstin Pfister; Dago Mazur; Jürgen Vormann; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2007-01-08       Impact factor: 5.191

Review 6.  Safety considerations of fluoroquinolones in the elderly: an update.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

7.  Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro.

Authors:  M Menschik; J Neumüller; C W Steiner; L Erlacher; M Köller; R Ullrich; W Graninger; W B Graninger
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

8.  Effects of the Des-F(6)-quinolone garenoxacin (BMS-284756), in comparison to those of ciprofloxacin and ofloxacin, on joint cartilage in immature rats.

Authors:  Eva Maria Kappel; Mehdi Shakibaei; Akintunde Bello; Ralf Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2002-10       Impact factor: 5.191

Review 9.  Fluoroquinolones in the elderly: safety considerations.

Authors:  Ralf Stahlmann; Hartmut Lode
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

10.  Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.

Authors:  R Stahlmann; U Zippel; C Förster; R Schwabe; M Shakibaei; H J Merker; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.